<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03620487</url>
  </required_header>
  <id_info>
    <org_study_id>012-DL-01</org_study_id>
    <nct_id>NCT03620487</nct_id>
  </id_info>
  <brief_title>Detection of Dengue Virus in Plasma of Patients in Nepal</brief_title>
  <official_title>Pathogen Detection and Host Response in Plasma of Patients With Dengue and Dengue Fever Like Illnesses in Nepal.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karius, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tribhuvan University, Nepal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karius, Inc.</source>
  <brief_summary>
    <textblock>
      To test whether Karius Infectious Disease Diagnostic Sequencing assay can detect Dengue Virus
      in plasma from suspected cases of Dengue or Dengue Fever like-illnesses from samples
      collected as part of a hospital-based multi-site study conducted in Nepal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood samples will be obtained from consented subjects as part of a hospital-based multi-site
      study conducted in Nepal and will be shipped to Karius, Redwood City, CA.

      The investigators will test whether the Karius test can detect Dengue Virus in plasma from
      those suspected cases and measure the performance of the Karius test against standard tests
      (PCR, ELISA test and neutralization assays) used to determine a final diagnosis of Dengue
      Fever.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">December 21, 2016</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity of the Karius Test in detecting the Dengue Virus in plasma.</measure>
    <time_frame>3 years</time_frame>
    <description>Test the sensitivity and specificity of the Karius Infectious Disease Diagnostic Sequencing Assay in detecting the Dengue Virus in plasma (measured in molecules per mL) from suspected cases of Dengue Virus from a hospital-based multicentered study conducted in Nepal.</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Dengue Fever</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with Dengue or Dengue Fever-like illnesses in Nepal.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years and older, suspected of having Dengue or Dengue Fever-like illnesses.

        Exclusion Criteria:

          -  Inability to understand instructions and comply with study-related procedures,
             inability to understand and/or sign informed consent, any condition that will prevent
             the subject from completing the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krishna Manandhar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tribhuvan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tribhuvan University</name>
      <address>
        <city>Kirtipur</city>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 11, 2018</study_first_submitted>
  <study_first_submitted_qc>August 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NGS</keyword>
  <keyword>Sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dengue</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

